- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $289.5M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $290.49M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5.44M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $5.44M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $285.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $322.4M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $300.61M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $325.29M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $63.16M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $56.97M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $429.48M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $431.04M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $376.28M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $429.15M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $959.75M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.01B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 132.33M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $5.67M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$8.47M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.09 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $40.89M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $5.03M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$12.08M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$18.86M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $38.34M |
| Revenue | Q1 2025 · Mar 31, 2024 | $64.18M |